BMC Nephrology (Feb 2024)

Optimising diagnosis and management of kidney disease: an implementation trial of a clinical decision support system future health today

  • Hannah Wallace,
  • Qiumian Wang,
  • Tanita Botha,
  • Barbara Hunter,
  • Natalie Lumsden,
  • Craig Nelson

DOI
https://doi.org/10.1186/s12882-024-03489-y
Journal volume & issue
Vol. 25, no. 1
pp. 1 – 6

Abstract

Read online

Abstract Background Chronic kidney disease affects more than 10% of the world’s population and is a non-communicable disease of global concern and priority. There is a significant implementation gap between best practice guideline recommendations and current kidney disease management. Previous research has shown the need to partner with primary care to improve education, collaboration, and kidney disease awareness. This implementation trial will explore use of an innovative clinical decision support software, Future Health Today, to improve screening, diagnosis, and management of kidney disease in primary care. The program will be supported by tertiary care outreach services. The primary aim is to test the hypothesis that the Future Health Today implementation program will improve screening, diagnosis, and management of kidney disease. Secondary aims are to evaluate primary care satisfaction and broader health service impacts. Methods This pre-post implementation trial using an interrupted time series design will evaluate the clinical and service outcomes of Future Health Today, using a mixed methods study in twenty general practices with an estimated population size of 150,000. Deidentified patient data will be extracted from participating practices to examine the primary aims of the study. Surveys and semi-structured interviews with general practice will inform secondary hypotheses. Data linkage between primary care and tertiary care data will examine the broader health service impacts. Discussion This investigator driven trial will assess the impact of Future Health Today software coupled with education and clinical outreach support. Investigators hypothesise that there will be improvement in appropriate screening, diagnosis, and management of kidney disease. This program has the potential to be scaled more broadly. Trial Registration Australian New Zealand Clinical Trial Registry: ACTRN12623001096640.

Keywords